Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Artificial Intelligence Engine Predicts EGHT Stock to Gain 4% by June 1
10:49am, Thursday, 04'th May 2023
The world's foremost artificial intelligence stock trading algorithm, An-E, predicts that 8×8 (NASDAQ: EGHT ) stock will gain 4% by June 1. An-E (pronounced Annie) has made this kind of prediction be
Artificial Intelligence Engine Predicts ATEC Stock to Gain 5.5% by June 1
10:42am, Thursday, 04'th May 2023
The world's foremost artificial intelligence stock trading algorithm, An-E, predicts that Alphatec (NASDAQ: ATEC ) stock will gain 5.5% by June 1. An-E (pronounced Annie) has made this kind of predict
J&J Consumer-Health IPO Stock Kenvue to Raise $3.8 Billion
10:15am, Thursday, 04'th May 2023
Kenvue, which owns brands including Tylenol, Band-Aid, and Neutrogena, will begin trading Thursday. Shares were priced higher than an earlier range.
3 Must-Buy Blue-Chip Stocks if the Market Retests 2022 Lows
05:04am, Thursday, 04'th May 2023
We've had a strange market so far in 2023, but one that's at least forced investors to look for quality stocks. Despite all the action so far, we're not necessarily out of the woods (more on that in a
Johnson & Johnson's Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021
07:38pm, Wednesday, 03'rd May 2023
A unit of Johnson & Johnson is headed for the biggest initial public offering in more than a year after its shares were priced near the top of the expected range Wednesday evening.
J&J Prices Consumer Unit IPO at $22 a Share
05:55pm, Wednesday, 03'rd May 2023
The listing of the Tylenol maker would be by far the biggest initial public offering so far this year.
2 Stocks to Buy With $200 That Can Survive Any Recession
10:00am, Wednesday, 03'rd May 2023
Johnson & Johnson is a leader in an industry that remains relatively stable regardless of the economy. Amazon is a leader in several areas, from online advertising to e-commerce and cloud computing.
Artificial Intelligence Engine Predicts LYTS Stock to Gain 9% by May 30
09:43am, Wednesday, 03'rd May 2023
The world's foremost artificial intelligence stock trading algorithm, An-E, predicts that LSI Industries (NASDAQ: LYTS ) stock will gain 9% by May 30. An-E (pronounced Annie) has made this kind of pre
How Long Could It Take for Johnson & Johnson's Dividend Yield to Get to 5%?
09:09am, Wednesday, 03'rd May 2023
Johnson & Johnson has an excellent track record for increasing its dividend payments over the years. If it continues to raise its payout, investors could end up getting 5% of the original investment b
J&J's consumer health business Kenvue is going public this week. Here's what to know
08:38am, Wednesday, 03'rd May 2023
J&J's consumer health spinoff Kenvue is expected to set an initial public offering price Wednesday night and trade Thursday on the New York Stock Exchange.
Only 2 Companies Are AAA Rated As U.S. Risks Being A Deadbeat
08:00am, Wednesday, 03'rd May 2023
Lawmakers are playing chicken with the debt ceiling. Luckily there are still two U.S. S&P 500 companies left with AAA credit ratings.
2 Incredibly Cheap Dividend Stocks to Buy in May
09:45am, Tuesday, 02'nd May 2023
Top-shelf dividend stocks have a strong track record of outperforming the broader markets during an economic recession. Amgen and Johnson & Johnson are two elite dividend-paying pharma stocks that tra
Better Growth Stock: Johnson & Johnson vs. Intuitive Surgical
07:20am, Tuesday, 02'nd May 2023
Johnson & Johnson has kept its business stable and dividend consistent for years. Intuitive Surgical has a bright future in the minimally invasive surgery market.
The 7 Best Dividend Stocks to Buy for May 2023
02:22pm, Monday, 01'st May 2023
As the overall stock market remains choppy, plenty of investors may be considering which dividend stocks to buy for steady, reliable returns. In the near term, stocks offering average- to above-avera
J&J's Kenvue spinoff to hit IPO market this week in the biggest deal since late 2021
01:49pm, Monday, 01'st May 2023
Johnson & Johnson's consumer health company Kenvue is expected to hit the initial public offering market this week and mark the largest deal since late 2021.
